Related Experiment Video
Updated: Feb 11, 2026
13:38
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
12.7K
Innovative Drug and Prodrug Candidates in Cancer Treatment Targeting TP53 Mutations: Challenge and Hope
Raed M Al-Zoubi1,2,3, Mai Elaarag2, Ayman A Zarour4
1Department of Biomedical Sciences, QU-Health, College of Health Sciences, Qatar University, Doha, Qatar.
Drug Development Research
|February 10, 2026
Summary
Mutations in the TP53 gene drive cancer by enhancing tumor growth and resistance. This review explores novel therapies targeting these TP53 mutations, offering hope for improved cancer treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The TP53 gene is a critical tumor suppressor, essential for genomic stability.
- TP53 mutations, especially missense types, confer gain-of-function properties, promoting cancer progression, metastasis, and treatment resistance.
- Understanding these mutations is key to developing targeted cancer therapies.
Purpose of the Study:
- To review the mechanisms of TP53 mutations and their role in tumorigenesis.
- To assess novel therapeutic strategies and drug candidates targeting TP53 mutations in various cancers.
- To highlight emerging techniques for restoring wild-type p53 function or degrading mutant p53.
Main Methods:
- Literature review of studies on TP53 mutations and targeted therapies.
- Analysis of mechanisms of action for various drug classes (small-molecule correctors, statins, Hsp90 inhibitors, Eprenetapopt, COTI-2).
- Investigation of therapeutic potential in leukemia, lung, breast, and ovarian cancers.
Main Results:
- TP53 mutations significantly impact cancer progression through gain-of-function mechanisms.
- Several novel therapeutic agents show promise in preclinical and clinical investigations.
- Emerging strategies aim to restore normal p53 function or eliminate mutant forms.
Conclusions:
- Targeting TP53 mutations represents a promising avenue for innovative cancer treatment.
- Further research is crucial to overcome challenges like drug resistance and pathway complexity.
- These approaches offer potential for improved patient outcomes in multiple malignancies.
Related Concept Videos
01:30Prodrugs
4.4K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.4K
01:39Mutations
94.6K
Overview
94.6K
00:36Viral Mutations
40.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:21Cancers Originate from Somatic Mutations in a Single Cell
15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K